Physician Assistant · Lexington, KY
NPI
1639579196
Since 2014
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
740 S Limestone Ste D200
Lexington, KY, 40536
Phone (859) 323-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,604
138 services
Medicare patients, 2024
85
Average age 62
Drug cost, 2024
$7.1M
1,014 prescriptions
Company payments, 2025
$84
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy Stuffelbeam was code 99214 (office e&m - established), 64 times for 43 patients. In total Amy Stuffelbeam billed 138 services in 5 codes, and Medicare paid $9,604.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 64 | 43 | $52.98 | $3,391 |
| 99214 Office E&M - Established | Office | 41 | 28 | $76.75 | $3,147 |
| 99215 Office E&M - Established | Facility | 15 | 14 | $91.29 | $1,369 |
By year: 2022 $8,381 for 145 services; 2023 $7,017 for 131 services; 2024 $9,604 for 138 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy Stuffelbeam prescribed most often to Medicare patients was Stelara (Ustekinumab), with 189 prescriptions and refills. In total Amy Stuffelbeam wrote 1,014 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 189 | 239 | 26 | $4.9M |
| Omeprazole Generic | 72 | 160 | 18 | $459 |
| Rinvoq Upadacitinib | 58 | 58 | Under 11 | $374K |
| Mesalamine Generic | 52 | 94 | Under 11 | $29K |
| Dicyclomine Hcl Generic | 39 | 47 | 15 | $687 |
| Humira(Cf) Pen Adalimumab | 38 | 38 | Under 11 | $378K |
| Balsalazide Disodium Generic | 36 | 70 | Under 11 | $8,293 |
| Azathioprine Generic | 35 | 69 | Under 11 | $1,405 |
| Pantoprazole Sodium Generic | 35 | 89 | 11 | $579 |
| Linzess Linaclotide | 34 | 60 | Under 11 | $31K |
| Ondansetron Hcl Generic | 31 | 31 | Under 11 | $397 |
| Skyrizi On-Body Risankizumab-Rzaa | 30 | 56 | Under 11 | $587K |
| Humira Pen Adalimumab | 29 | 29 | Under 11 | $242K |
| Mesalamine Er Mesalamine | 26 | 34 | Under 11 | $6,913 |
| Sulfasalazine Generic | 22 | 31 | Under 11 | $633 |
Brand drugs: 551 claims; generic drugs: 463 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy Stuffelbeam $84 ($84 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $84.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.